Hepatocellular carcinoma

Open Access
Surgery-centered integrated strategies for personalized hepatocellular carcinoma care
Yuhan Cui, Zuchao Du, Jiahao Xu, Lihui Gu, Jiaqi Du, Mingda Wang and Tian Yang

Cancer Biology & Medicine August 2026, 23 (8) 1108-1127; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0045
Open Access
How the gut microbiome affects the immunotherapy response in hepatocellular carcinoma
Mengrui Wu, Yating Zhang and Jun Yu

Cancer Biology & Medicine May 2026, 23 (5) 561-579; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0761
Open Access
Lenvatinib triggers an EGR1-ZNF768-SLC7A11 adaptive response to limit ferroptosis-mediated therapeutic efficacy in hepatocellular carcinoma
Jialei Hua, Shuya Zhao, Changsen Bai, Ranliang Cui, Yichao Wang, Yang Liu, Yueguo Li and Dong Dong

Cancer Biology & Medicine May 2026, 20250814; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0814
Open Access
Lactate drives immune resistance via a pharmaceutically reversible H3K18la-KIF20A-c-Myc-PD-L1 axis in hepatocellular carcinoma
Shujia Chen, Lili Zhao, Ping Han, Jie Liu, Jiancun Hou, Xiaomei Liu, Qiang Zhao, Rongqi Wang, Fengmei Wang and Jia Li

Cancer Biology & Medicine April 2026, 20260110; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0110
Open Access
Novel diagnostic and therapeutic strategies based on PANoptosis for hepatocellular carcinoma
Jie Xiang, Yukai Li, Shengmin Mei, Zhiyan Ou, Li Wang, Yang Ke and Zhiwei Li

Cancer Biology & Medicine August 2025, 22 (8) 928-939; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0150
Open Access
Comprehensive strategies for management of postoperative hyper-progression recurrence (HPR) of hepatocellular carcinoma: a 12-year large sample multi-center study
Lunan Qi, Jingxuan Xu, Yuanyuan Chen, Zhan Lu, Min Zhou, Yingwu Huang, Yongchi Ling, Hai Huang, Yuchong Peng, Tao Peng, Bangde Xiang and Liang Ma

Cancer Biology & Medicine August 2025, 22 (8) 964-987; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0514
Open Access
Comprehensive strategies for management of postoperative hyper-progression recurrence (HPR) of hepatocellular carcinoma: a 12-year large sample multi-center study
Lunan Qi, Jingxuan Xu, Yuanyuan Chen, Zhan Lu, Min Zhou, Yingwu Huang, Yongchi Ling, Hai Huang, Yuchong Peng, Tao Peng, Bangde Xiang and Liang Ma

Cancer Biology & Medicine July 2025, 20240514; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0514
Open Access
Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis
Li Yuan, Yue Wang, Junjie Cheng, Shilin Lin, Aying Ma, Kunchao Li, Yiming Zheng, Zhaochong Zeng, Aiwu Ke, Chao Gao and Shisuo Du

Cancer Biology & Medicine April 2025, 22 (4) 396-411; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0544
Open Access
Neoepitope BTLA^P267L-specific TCR-T cell immunotherapy unlocks precision treatment for hepatocellular carcinoma
Fang Liu, Hua Chen, Suxin Wu, Chenlu Zhu, Mingji Zhang, Wei Rui, Dong Zhou, Yang Wang, Xin Lin, Xueqiang Zhao and Yunbin Ye

Cancer Biology & Medicine April 2025, 22 (4) 412-432; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0434
Open Access
Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma
Jinyan Chen, Huigang Li, Jianyong Zhuo, Zuyuan Lin, Zhihang Hu, Chiyu He, Xiang Wu, Yiru Jin, Zhanyi Lin, Renyi Su, Yiyang Sun, Rongsen Wang, Jiancai Sun, Xuyong Wei, Shusen Zheng, Di Lu and Xiao Xu

Cancer Biology & Medicine November 2024, 21 (11) 1033-1049; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0267

Main menu

User menu

Search

Hepatocellular carcinoma

Pages

Navigate

More Information

For Authors

Journal Services